Richie Gray, aka the Collision King, is using a cerebral approach to think about how players hit each other—and making the ...

Report card grades and standardized test scores should rise and fall together, since they measure the same group of students ...

Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to announce the signing of a Sale and Purchase ...

Psyence BioMed (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health ...

“ADDRI’s leadership in asbestos-related disease makes Australia a compelling setting for a TT-4 investigator-initiated trial,” said Peter Molloy, Chief Executive Officer, Cyncado Therapeutics. “We are ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind” or the "Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

The modern world runs on data. Every click, purchase, diagnosis, and interaction feeds massive systems that shape our reality ...

Full Circle Lithium Corp. ("FCL" or the "Company") , a US-based lithium-ion battery fire extinguishing products manufacturer, is excited to announce is pleased to announce that its common shares have ...

The UK government has set out an ambitious plan to phase out animal testing in scientific studies within five years, with ...

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 millionEC and U.S. FDA label updates for CARVYKTI® to ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today ...

Creative Media & Community Trust (NASDAQ: CMCT) ("CMCT or the "Company") announced today it has entered into a definitive agreement to sell its lending division to PG FR Holding, LLC, an affiliate of ...